UL Solutions Inc. (ULS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a ch ...

Getty Images Holdings, Inc. (GETY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual in ...

Investors might want to bet on Coya Therapeutics, Inc. (COYA) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. ...

Investors might want to bet on KindlyMD, Inc. (NAKA) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.S ...

Shares of Nektar Therapeutics (NKTR) have gained 79.9% over the past four weeks to close the last trading session at $68.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $129.86 indicates a potential upside of 89.8%.The mean estimate comprises seven short-term price targets with a standard deviation of $25.1. While the lowest estimate of $102.00 indicates a 49.1% increase fro ...

Shares of TPG Mortgage Investment Trust (MITT) have been struggling lately and have lost 6.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bu ...

EverQuote (EVER) has been on a downward spiral lately with significant selling pressure. After declining 33.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscill ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Albemarle (ALB) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Albemarle currently has an averag ...

Wall Street analysts forecast that Teleflex (TFX) will report quarterly earnings of $3.73 per share in its upcoming release, pointing to a year-over-year decline of 4.1%. It is anticipated that revenues will amount to $925.96 million, exhibiting an increase of 16.4% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed t ...

Core Insights - Universal Insurance Holdings (UVE) reported quarterly earnings of $2.17 per share, exceeding the Zacks Consensus Estimate of $1.3 per share and significantly up from $0.25 per share a year ago, indicating strong performance [1] - The earnings surprise of +66.92% reflects the company's consistent ability to surpass consensus EPS estimates over the last four quarters [2] Financial Performance - The company achieved revenues of $407.93 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 9.37% and up from $384.81 million year-over-year [3] - Universal Insurance has also consistently exceeded consensus revenue estimates in the past four quarters [3] Stock Performance and Outlook - Despite the strong earnings report, Universal Insurance shares have declined approximately 10.6% since the beginning of the year, contrasting with the S&P 500's slight decline of 0.1% [4] - The company's future stock performance will largely depend on management's commentary during the earnings call and the subsequent earnings outlook [4][5] Earnings Estimates and Industry Context - Current consensus EPS estimate for the upcoming quarter is $1.32 on revenues of $370.25 million, while for the current fiscal year, it is $3.34 on revenues of $1.51 billion [8] - The Insurance - Property and Casualty industry is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable environment for stock performance [9]